Skip to Main Content

Paper Details

Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis.
bioRxiv
2
2022
RNAi molecules, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 genome, Spike, siRNA, siRNA target sites, siRNAs
Author NameAffiliation
Myra HosmilloUniversity of Cambridge
Ian GoodfellowUniversity of Cambridge
Gregory J HannonCRUK Cambridge Institute, University of Cambridge
  • 1 - 3

Datasets

Release 1.2